Cargando…
Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208505/ http://dx.doi.org/10.1038/bjc.2011.411 |
| _version_ | 1782215622509199360 |
|---|---|
| author | Khan, O A Blann, A D Payne, M J Middleton, M R Protheroe, A S Talbot, D C Taylor, M Kirichek, O Han, C Patil, M Harris, A L |
| author_facet | Khan, O A Blann, A D Payne, M J Middleton, M R Protheroe, A S Talbot, D C Taylor, M Kirichek, O Han, C Patil, M Harris, A L |
| author_sort | Khan, O A |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3208505 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2011 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-32085052012-06-07 Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer Khan, O A Blann, A D Payne, M J Middleton, M R Protheroe, A S Talbot, D C Taylor, M Kirichek, O Han, C Patil, M Harris, A L Br J Cancer Corrigendum Nature Publishing Group 2011-10-11 2011-10-11 /pmc/articles/PMC3208505/ http://dx.doi.org/10.1038/bjc.2011.411 Text en Copyright © 2011 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Corrigendum Khan, O A Blann, A D Payne, M J Middleton, M R Protheroe, A S Talbot, D C Taylor, M Kirichek, O Han, C Patil, M Harris, A L Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer |
| title | Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer |
| title_full | Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer |
| title_fullStr | Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer |
| title_full_unstemmed | Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer |
| title_short | Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer |
| title_sort | continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208505/ http://dx.doi.org/10.1038/bjc.2011.411 |
| work_keys_str_mv | AT khanoa continuouslowdosecyclophosphamideandmethotrexatecombinedwithcelecoxibforpatientswithadvancedcancer AT blannad continuouslowdosecyclophosphamideandmethotrexatecombinedwithcelecoxibforpatientswithadvancedcancer AT paynemj continuouslowdosecyclophosphamideandmethotrexatecombinedwithcelecoxibforpatientswithadvancedcancer AT middletonmr continuouslowdosecyclophosphamideandmethotrexatecombinedwithcelecoxibforpatientswithadvancedcancer AT protheroeas continuouslowdosecyclophosphamideandmethotrexatecombinedwithcelecoxibforpatientswithadvancedcancer AT talbotdc continuouslowdosecyclophosphamideandmethotrexatecombinedwithcelecoxibforpatientswithadvancedcancer AT taylorm continuouslowdosecyclophosphamideandmethotrexatecombinedwithcelecoxibforpatientswithadvancedcancer AT kiricheko continuouslowdosecyclophosphamideandmethotrexatecombinedwithcelecoxibforpatientswithadvancedcancer AT hanc continuouslowdosecyclophosphamideandmethotrexatecombinedwithcelecoxibforpatientswithadvancedcancer AT patilm continuouslowdosecyclophosphamideandmethotrexatecombinedwithcelecoxibforpatientswithadvancedcancer AT harrisal continuouslowdosecyclophosphamideandmethotrexatecombinedwithcelecoxibforpatientswithadvancedcancer |